ACCOMPLISH the goal: hypertension and beyond.
Siragy
Helmy M
HM
Department of Medicine and Hypertension Center, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA. hms7a@virginia.edu
D017311:Amlodipine / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D018570:Risk Assessment
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001552:Benzazepines; D002121:Calcium Channel Blockers; D006852:Hydrochlorothiazide; D017311:Amlodipine; C044946:benazepril